The Cell Therapy stream examines recent advances in analytical characterisation, gene editing, CMC and regulatory strategies. In-depth case studies will address the practical challenges faced during the scale-up and manufacture of cell therapies and viral vectors, addressing both autologous and allogeneic production platforms.

Conferences Include:

Keynote Presentations:

Paula Alves, PhD, CEO, iBET

Vered Caplan, CEO, Octomera and Orgenesis